OnabotulinumtoxinA Improves Sleep Quality in Patients with Chronic Migraine: A Prospective Real-World Study
Preliminary real-world evidence is provided that OBT-A treatment is associated with improved subjective sleep quality in patients with chronic migraine and the mechanisms underlying sleep improvement are still unclear, although the lack of statistical significance warrants cautious interpretation.